CBD Research for Dogs in 2026: What the Latest Studies Show
When you’re considering CBD for your dog, you’re not looking for trends.
You’re looking for evidence.
Is this something veterinarians are actually studying?
Is there real research behind it?
Is it safe for long-term use?
Over the past decade, veterinary CBD research has moved from anecdotal reporting to structured, peer-reviewed clinical trials. Since 2018, universities have published controlled studies examining cannabidiol’s role in canine epilepsy, osteoarthritis, pharmacokinetics, safety and long-term tolerability.
So what does the current evidence, as of 2026, actually show?
Why Veterinary CBD Research Matters
CBD should be approached with the same clinical rigour as any other therapy.
For dogs living with epilepsy, osteoarthritis or other chronic conditions, any additional therapy must be guided by clinical evidence, appropriate dosing and veterinary oversight.
Research helps determine what is measurable, what is safe, and where CBD may – or may not – have a clinical role.
The goal is not hype. It’s clarity.
CBD Epilepsy Research in Dogs
One of the most referenced clinical trials on CBD for canine epilepsy was published in 2019 and examined cannabidiol as an adjunct therapy for dogs with idiopathic epilepsy.
In this randomized, placebo-controlled trial, dogs receiving CBD alongside their usual anti-epileptic drugs showed a statistically significant reduction in seizure frequency compared with placebo, and plasma CBD levels were correlated with seizure reduction.
In one 2023 study, higher oral doses of CBD were associated with fewer seizure days compared with placebo, though liver enzyme monitoring was recommended due to increases observed with treatment.
These studies suggest CBD may act as supportive therapy in canine epilepsy when used alongside conventional anti-seizure medications. It’s important to note:
- CBD does not replace prescribed anti-epileptic medication.
- Not all dogs respond the same way.
- Monitoring by a veterinarian is essential for safety and stability.
Epilepsy remains one of the most evidence-studied areas of veterinary CBD research to date.
CBD Arthritis Research in Dogs
Osteoarthritis is another area where controlled trials have examined CBD’s effects.
In a 2018 double-blind, placebo-controlled clinical study, dogs with osteoarthritis treated with CBD oil showed improvements in comfort and activity scores compared with placebo, and pharmacokinetic data suggested CBD was generally well tolerated.
Another randomized veterinary study indicated that higher daily doses of CBD or liposome-encapsulated CBD led to owner- and vet-reported quality-of-life improvements over 30 days.
Systematic reviews summarizing multiple canine studies have found that while CBD appears safe and may reduce pain scores, the overall certainty of evidence remains low and more high-quality trials are needed to confirm clinical efficacy.
Research into how CBD interacts with inflammatory pathways and the endocannabinoid system continues, given inflammation’s key role in osteoarthritis.
Again, this is not about curing arthritis- it’s about supporting comfort and mobility in some dogs.
What About Anxiety and Behavioural Conditions?
Early research has begun to examine CBD’s potential role in canine anxiety and stress-related behaviours. Some studies suggest cannabidiol may influence stress response pathways and behavioural indicators, but results are still preliminary, with dosing variability and formulation differences posing challenges.
For dogs with behavioural concerns, CBD should be viewed as one component of a broader strategy, alongside behavioural training, environmental adjustments, and conventional therapies.
Research on CBD for Diabetes in Dogs
When it comes to diabetes, clinical research remains limited.
While scientists recognise the endocannabinoid system plays a role in metabolic regulation and immune signalling, there are currently no large-scale clinical trials demonstrating CBD as a treatment for diabetes in dogs.
CBD does not replace insulin therapy.
Some laboratory research has explored how cannabinoids may influence inflammatory balance and stress pathways relevant to chronic disease, but stronger evidence is still needed before drawing firm conclusions.
Is CBD Safe for Dogs Long Term?
Safety remains one of the most important areas of ongoing CBD research.
Current veterinary studies suggest CBD is generally well tolerated when appropriately dosed. However, mild elevations in liver enzymes have been observed in some cases, and drug interactions – particularly with anti-epileptic medications – are possible.
For this reason, veterinarians may recommend:
- Baseline bloodwork
- Ongoing liver enzyme monitoring
- Gradual dose titration
- Review of concurrent medications
CBD is not a cure. It is best considered a complementary therapy within a broader veterinary care plan. Product quality, cannabinoid consistency, and absence of contaminants are critical factors in clinical use.
Key Takeaways from Current CBD Research for Dogs
- The strongest evidence is in epilepsy and osteoarthritis.
- CBD does not replace conventional treatments.
- Safety monitoring is recommended.
- Evidence for anxiety and metabolic conditions is still emerging.
- Individual responses vary.
- Veterinary oversight is essential.
A Measured, Evidence-Based Approach
Veterinary CBD research continues to expand, but thoughtful care comes first.
CBD may be one component of a broader management strategy that includes medication, nutrition, mobility support and regular veterinary assessment.
The goal isn’t dramatic change.
It’s comfort. Stability. More good days.
If you’re considering CBD for your dog, reach out to us HERE to discover your local prescribing vet or contact the CBD Vets Australia team HERE with any questions.
This article reflects peer-reviewed veterinary literature available as of early 2026. Research continues to evolve.
